EIKN EIKON THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, EIKON THERAPEUTICS INC reported revenue of n/a, net income of −$88.4M and diluted EPS of −$1.63.
EIKN quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$88.4M, EPS −$1.63
- Quarter ended Mar 31, 2026: revenue n/a, net income −$83.0M, EPS −$2.46
- Quarter ended Jun 30, 2025: revenue n/a, net income −$105M, EPS −$36.94
- Quarter ended Mar 31, 2025: revenue n/a, net income −$68.2M, EPS −$26.91
EIKN balance sheet
- Jun 30, 2026: cash $143M, total assets $780M, total liabilities $313M, shareholders' equity $467M
- Mar 31, 2026: cash $161M, total assets $851M, total liabilities $300M, shareholders' equity $551M
- Dec 31, 2025: cash $105M, total assets $595M, total liabilities $312M, shareholders' equity −$879M